Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

Clinical trial NCT01277601 · COMPLETED

Trial details

NCT number: NCT01277601
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2011-04-01
Primary completion: 2014-08-01
Enrollment: 751

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.